Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection
- PMID: 11843219
- DOI: 10.1046/j.1468-3083.2001.00288.x
Resolution of recurrent perianal condylomata acuminata by topical cidofovir in patients with HIV infection
Abstract
Anogenital condylomata acuminata are the most frequent clinical manifestation of genital human papillomavirus (HPV) infection. Association between human immunodeficiency virus (HIV) and HPV infections is frequent (range: 26-60% in males). Topical cidofovir (a nucleotide analogue antiviral drug active against a broad range of DNA viruses) is a potential treatment for anogenital warts in immunocompromised patients. We treated three HIV-infected patients with HPV perianal condylomas with topical 1% cidofovir in flexible collodion once a day for 2 weeks. The treatment resulted in complete clearance of the HPV lesions. The patients experienced mild transient erythema without any other side-effects. None of the patients relapsed during the 10-14-month follow-up period.
Similar articles
-
Intralesional or topical cidofovir (HPMPC, VISTIDE) for the treatment of recurrent genital warts in HIV-1-infected patients.AIDS. 1999 Oct 1;13(14):1978-80. doi: 10.1097/00002030-199910010-00023. AIDS. 1999. PMID: 10513659 No abstract available.
-
Topical cidofovir for severe cutaneous human papillomavirus and molluscum contagiosum infections in patients with HIV/AIDS. A pilot study.J Eur Acad Dermatol Venereol. 2000 Nov;14(6):484-8. doi: 10.1046/j.1468-3083.2000.00184.x. J Eur Acad Dermatol Venereol. 2000. PMID: 11444271 Clinical Trial.
-
[Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].Ann Dermatol Venereol. 2004 May;131(5):445-9. doi: 10.1016/s0151-9638(04)93637-x. Ann Dermatol Venereol. 2004. PMID: 15235531 Clinical Trial. French.
-
Topical and intralesional cidofovir: a review of pharmacology and therapeutic effects.J Am Acad Dermatol. 1998 Nov;39(5 Pt 1):741-5. doi: 10.1016/s0190-9622(98)70046-5. J Am Acad Dermatol. 1998. PMID: 9810890 Review.
-
A review of topical and intralesional cidofovir.Dermatol Online J. 2000 Sep;6(1):3. Dermatol Online J. 2000. PMID: 11328613 Review.
Cited by
-
Structures and membrane interactions of human OAT1 in complex with clinical used drugs.Sci Adv. 2025 Feb 14;11(7):eads5405. doi: 10.1126/sciadv.ads5405. Epub 2025 Feb 14. Sci Adv. 2025. PMID: 39951534 Free PMC article.
-
Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.AIDS. 2013 Feb 20;27(4):545-51. doi: 10.1097/QAD.0b013e32835a9b16. AIDS. 2013. PMID: 23032420 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical